The study of men in Canada, Poland and the United States found that those men treated with the PSD502 spray five minutes before intercourse were able to delay ejaculation up to five times longer than those who used a placebo. In addition, men who used the spray and their partners reported improved sexual satisfaction.
A spray touted as the first potential treatment for premature ejaculation has proved effective in a second study, according to the company that developed it.
PSD502 — which combines the drugs lidocaine and prilocaine — is sprayed on the head of the penis before intercourse.
The findings, presented recently at the annual meeting of the Sexual Medicine Society of North America, are consistent with those from a previous trial in Europe, according to San Diego-based Sciele Pharma Inc.

No User Responded In This Post
Before Leave Your Comments Here Click Below On Our Sponsors...